Clinical Trials Browser

Interventional × Solid Tumors × oblimersen × Clear all

NCT00636545 2012-04-06

Genasense as a 2-hour Intravenous Infusion in Subjects With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors